4.7 Article

Palmitoylation of human FasL modulates its cell death-inducing function

期刊

CELL DEATH & DISEASE
卷 1, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/cddis.2010.62

关键词

Fas ligand; proteolysis; ADAM10 processing; rafts; palmitoylation

资金

  1. Centre National de la Recherche Scientifique (CNRS)
  2. Ligue nationale contre le cancer (LNCC)
  3. Association pour la Recherche contre le Cancer (ARC)
  4. Institut National du Cancer (INCa)
  5. Agence Nationale de la Recherche [ANR-08-PCVI-0034-01]
  6. German Research Foundation [ZO110/4-1, ZO110/2-1/2]
  7. German National Academic Foundation
  8. Agence Nationale de la Recherche (ANR) [ANR-08-PCVI-0034] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

Fas ligand (FasL) is a transmembrane protein that regulates cell death in Fas-bearing cells. FasL-mediated cell death is essential for immune system homeostasis and the elimination of viral or transformed cells. Because of its potent cytotoxic activity, FasL expression at the cell surface is tightly regulated, for example, via processing by ADAM10 and SPPL2a generating soluble FasL and the intracellular fragments APL (ADAM10-processed FasL form) and SPA (SPPL2a-processed APL). In this study, we report that FasL processing by ADAM10 counteracts Fas-mediated cell death and is strictly regulated by membrane localization, interactions and modifications of FasL. According to our observations, FasL processing occurs preferentially within cholesterol and sphingolipid-rich nanodomains (rafts) where efficient Fas-FasL contact occurs, Fas receptor and FasL interaction is also required for efficient FasL processing, and FasL palmitoylation, which occurs within its transmembrane domain, is critical for efficient FasL-mediated killing and FasL processing. Cell Death and Disease (2010) 1, e88; doi: 10.1038/cddis.2010.62; published online 21 October 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据